AU8374575A - Peptidecylopropylamides having lh-rh/fsh-activity - Google Patents

Peptidecylopropylamides having lh-rh/fsh-activity

Info

Publication number
AU8374575A
AU8374575A AU83745/75A AU8374575A AU8374575A AU 8374575 A AU8374575 A AU 8374575A AU 83745/75 A AU83745/75 A AU 83745/75A AU 8374575 A AU8374575 A AU 8374575A AU 8374575 A AU8374575 A AU 8374575A
Authority
AU
Australia
Prior art keywords
peptidecylopropylamides
fsh
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU83745/75A
Other languages
English (en)
Inventor
Wolfgang Konig
Rolf Geiger
Jurgen Kurt Sandow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU8374575A publication Critical patent/AU8374575A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU83745/75A 1974-08-09 1975-08-07 Peptidecylopropylamides having lh-rh/fsh-activity Expired AU8374575A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438352A DE2438352A1 (de) 1974-08-09 1974-08-09 Peptidcyclopropylamide mit lh-rh/fshrh-wirkung

Publications (1)

Publication Number Publication Date
AU8374575A true AU8374575A (en) 1977-02-10

Family

ID=5922834

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83745/75A Expired AU8374575A (en) 1974-08-09 1975-08-07 Peptidecylopropylamides having lh-rh/fsh-activity

Country Status (10)

Country Link
JP (1) JPS5141359A (enrdf_load_stackoverflow)
AU (1) AU8374575A (enrdf_load_stackoverflow)
BE (1) BE832311A (enrdf_load_stackoverflow)
DE (1) DE2438352A1 (enrdf_load_stackoverflow)
DK (1) DK361375A (enrdf_load_stackoverflow)
FR (1) FR2281133A1 (enrdf_load_stackoverflow)
IL (1) IL47879A0 (enrdf_load_stackoverflow)
LU (1) LU73168A1 (enrdf_load_stackoverflow)
NL (1) NL7509259A (enrdf_load_stackoverflow)
SE (1) SE7508927L (enrdf_load_stackoverflow)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133507B2 (en) 2002-12-13 2012-03-13 Durect Corporation Oral drug delivery system
US8153149B2 (en) 2004-09-17 2012-04-10 Durect Corporation Controlled delivery system
US8415401B2 (en) 2007-12-06 2013-04-09 Durect Corporation Oral pharmaceutical dosage forms
US8956644B2 (en) 2006-11-03 2015-02-17 Durect Corporation Transdermal delivery systems
US9555113B2 (en) 2013-03-15 2017-01-31 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US9616055B2 (en) 2008-11-03 2017-04-11 Durect Corporation Oral pharmaceutical dosage forms
US10471001B2 (en) 2002-06-25 2019-11-12 Durect Corporation Short duration depot formulations
US11083796B2 (en) 2005-07-26 2021-08-10 Durect Corporation Peroxide removal from drug delivery vehicle
US11400019B2 (en) 2020-01-13 2022-08-02 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
US12274794B2 (en) 2016-07-06 2025-04-15 Orient Pharma Co., Ltd. Oral dosage form with drug composition, barrier layer and drug layer
US12433877B2 (en) 2021-01-12 2025-10-07 Durect Corporation Sustained release drug delivery systems and related methods

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59194069U (ja) * 1983-06-08 1984-12-24 大日本印刷株式会社 尿検査用カツプ
JPS6041859U (ja) * 1983-08-29 1985-03-25 栄研化学株式会社 血液診断用分析試験片
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
CA2466659A1 (en) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Anticancer agents

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10471001B2 (en) 2002-06-25 2019-11-12 Durect Corporation Short duration depot formulations
US10471002B2 (en) 2002-06-25 2019-11-12 Durect Corporation Short duration depot formulations
US11179326B2 (en) 2002-06-25 2021-11-23 Durect Corporation Short duration depot formulations
US9233160B2 (en) 2002-12-13 2016-01-12 Durect Corporation Oral drug delivery system
US8951556B2 (en) 2002-12-13 2015-02-10 Durect Corporation Oral drug delivery system
US8168217B2 (en) 2002-12-13 2012-05-01 Durect Corporation Oral drug delivery system
US8354124B2 (en) 2002-12-13 2013-01-15 Durect Corporation Oral drug delivery system
US8147870B2 (en) 2002-12-13 2012-04-03 Durect Corporation Oral drug delivery system
US8420120B2 (en) 2002-12-13 2013-04-16 Durect Corporation Oral drug delivery system
US9918982B2 (en) 2002-12-13 2018-03-20 Durect Corporation Oral drug delivery system
US8133507B2 (en) 2002-12-13 2012-03-13 Durect Corporation Oral drug delivery system
US8945614B2 (en) 2002-12-13 2015-02-03 Durect Corporation Oral drug delivery system
US8153152B2 (en) 2002-12-13 2012-04-10 Durect Corporation Oral drug delivery system
US9517271B2 (en) 2002-12-13 2016-12-13 Durect Corporation Oral drug delivery system
US8974821B2 (en) 2002-12-13 2015-03-10 Durect Corporation Oral drug delivery system
US8153149B2 (en) 2004-09-17 2012-04-10 Durect Corporation Controlled delivery system
US8846072B2 (en) 2004-09-17 2014-09-30 Durect Corporation Controlled delivery system
US8753665B2 (en) 2004-09-17 2014-06-17 Durect Corporation Controlled delivery system
US8153661B2 (en) 2004-09-17 2012-04-10 Durect Corporation Controlled delivery system
US11083796B2 (en) 2005-07-26 2021-08-10 Durect Corporation Peroxide removal from drug delivery vehicle
US8956644B2 (en) 2006-11-03 2015-02-17 Durect Corporation Transdermal delivery systems
US8415401B2 (en) 2007-12-06 2013-04-09 Durect Corporation Oral pharmaceutical dosage forms
US9655861B2 (en) 2007-12-06 2017-05-23 Durect Corporation Oral pharmaceutical dosage forms
US9592204B2 (en) 2007-12-06 2017-03-14 Durect Corporation Oral pharmaceutical dosage forms
US10206883B2 (en) 2007-12-06 2019-02-19 Durect Corporation Oral pharamaceutical dosage forms
US9884056B2 (en) 2008-11-03 2018-02-06 Durect Corporation Oral pharmaceutical dosage forms
US9616055B2 (en) 2008-11-03 2017-04-11 Durect Corporation Oral pharmaceutical dosage forms
US10328068B2 (en) 2008-11-03 2019-06-25 Durect Corporation Oral pharmaceutical dosage forms
US9572885B2 (en) 2013-03-15 2017-02-21 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US10300142B2 (en) 2013-03-15 2019-05-28 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US9907851B2 (en) 2013-03-15 2018-03-06 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US9855333B2 (en) 2013-03-15 2018-01-02 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US9555113B2 (en) 2013-03-15 2017-01-31 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US12274794B2 (en) 2016-07-06 2025-04-15 Orient Pharma Co., Ltd. Oral dosage form with drug composition, barrier layer and drug layer
US11400019B2 (en) 2020-01-13 2022-08-02 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
US11771624B2 (en) 2020-01-13 2023-10-03 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
US12433877B2 (en) 2021-01-12 2025-10-07 Durect Corporation Sustained release drug delivery systems and related methods

Also Published As

Publication number Publication date
DK361375A (da) 1976-02-10
JPS5141359A (enrdf_load_stackoverflow) 1976-04-07
SE7508927L (sv) 1976-02-10
DE2438352A1 (de) 1976-02-26
BE832311A (fr) 1976-02-11
FR2281133A1 (fr) 1976-03-05
LU73168A1 (enrdf_load_stackoverflow) 1977-04-13
NL7509259A (nl) 1976-02-11
IL47879A0 (en) 1975-11-25

Similar Documents

Publication Publication Date Title
JPS51102636A (en) Karaashashingazo no keiseihoho
JPS5113709A (en) Echiren no ensokajudotai no seizoho
AU8374575A (en) Peptidecylopropylamides having lh-rh/fsh-activity
JPS5144867A (en) Ichonidoobusareta p gatahandotaizairyono seizohoho
JPS5162206A (en) V gataenjin
JPS5119744A (en) Koseibutsushitsu xkk6222 no shinkyudotainoseiho
JPS511668A (en) Komekojojinzomai no seizoho
JPS511268A (en) Kokurui no atsupenkakohoho
JPS511666A (en) Kakokokuruifunmatsu no seizoho
JPS5113474A (en) Kendakueki no zoryubunrisochi
JPS5112906A (en) Mokuseihinno v katsutomentorikoho
JPS511661A (en) Kaatsukyoseitairyu nyoru kokurui no tankijoshahoho
JPS5123619A (en) Kogatatoransu no seizohoho
JPS5122372A (en) Gaaallas no fushokuhoho
JPS515281A (en) P gatanemachitsukuekishososeibutsu
JPS5132536A (en) P aminomechiruansokukosan no seizohoho
JPS5123463A (en) Fuintsukichuubu no fuinhenkeiyokogu
JPS5120271A (en) Taidenboshipaipu no seikeihoho
JPS5118187A (en) Kenzobutsuyori no hinansochi
JPS51102976A (en) Biniiruhausu no kankisochi
JPS5115105A (en) Judoki no kyusokukatsuteisonshitsunasuitsuchinguyokairo
JPS511554A (en) Senjohoriesuteru no seizoho
JPS511664A (en) Patsukuiryudemen no seizoho
JPS5148050A (en) V puuriino seizohoho
JPS5128483A (en) P gatakagobutsuhandotainiteiteikosetsushokusuru denkyokusoseibutsu